abstract |
A method useful for inhibiting the progression of urea cycle disorders and neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, and multiple sclerosis. The method comprises administering to a patient in need thereof an effective amount of a pharmaceutical composition comprising glyceryl tribenzoate and / or glyceryl dibenzoate. Preferably, a method comprising administering to a patient an effective amount of about 3 grams to about 10 grams once a day, based on a 50 kg patient. [Selection diagram] Fig. 1 |